| 000 | 01391 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515030145.0 | ||
| 264 | 0 | _c20060706 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 024 | 7 |
_a10.1053/j.seminoncol.2006.03.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLane, Heidi A | |
| 245 | 0 | 0 |
_aFuture directions in the treatment of hormone-sensitive advanced breast cancer: the RAD001 (Everolimus)-letrozole clinical program. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cApr 2006 |
||
| 300 |
_aS18-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAromatase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aLetrozole |
| 650 | 0 | 4 |
_aNeoplasms, Hormone-Dependent _xdrug therapy |
| 650 | 0 | 4 |
_aNitriles _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTriazoles _xtherapeutic use |
| 700 | 1 | _aLebwohl, David | |
| 773 | 0 |
_tSeminars in oncology _gvol. 33 _gno. 2 Suppl 7 _gp. S18-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.seminoncol.2006.03.024 _zAvailable from publisher's website |
| 999 |
_c16327619 _d16327619 |
||